EyePoint Pharmaceuticals, Inc. (EYPT) Social Stream
Featured Post From StockTwits About EYPT
$EYPT Nothing has changed except we have lost a few months.commoncentsinvestor, published June 2, 2020
STILL MOST IMPORTANT: There are 4.8M cataract eye surgeries done in the U.S. each year. If DEXYCU were to get just 10% of this market, at $595.00 per pop it would be $285,600,000 in revenues. What would the price per share be if that happened?
And growth won't stop there. Cataract surgery is growing at the rate of 8% per year. It is currently the most performed surgery in the U.S. And the baby boomers are now between 55 & 75 years of age. Massive amount of prospects there. Perfect product for the perfect time.
Also, estimated market for YUTIQ is over $550M Those investing at under $1 will reap rewards beyond their fondest expectations.